Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Editorial: Cancer Immunosurveillance.

Frontiers in immunology·2026

Same author

Rank-based learning: a novel high-throughput algorithm resilient to missing data and effective for datasets with small sample size.

Briefings in bioinformatics·2026

Same author

Breast cancer risk assessment: current challenges and the emerging role of blood-based protein biomarkers.

Journal of the National Cancer Institute·2025

Same author

Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Same author

A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone.

Cancer letters·2024

Same author

Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases.

JNCI cancer spectrum·2024

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Progress in mining the human proteome for disease applications.

¹Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. shanash@fhcrc.org

Omics : a Journal of Integrative Biology

|March 8, 2011

Summary

This summary is machine-generated.

Advanced proteomic technologies offer clinical insights complementing genomics. A strategic roadmap is crucial for proteomics research, focusing on resource development, biological variation, and disease-specific proteome characterization through collaborative efforts.

More Related Videos

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Area of Science:

Proteomics
Clinical Proteomics
Genomics

Background:

Current proteomic technologies enable deep analysis of the proteome.
These analyses have clinical relevance and complement genomics-based approaches.
Knowledge of the human proteome in health and disease requires further expansion.

Purpose of the Study:

To outline a strategic roadmap for guiding future proteomics efforts.
To emphasize key areas for advancement in proteomic research.
To foster a collaborative approach for comprehensive proteome understanding.

Main Methods:

Leveraging current technologies for in-depth proteome analysis.
Integrating proteomic data with genomics-based approaches.
Systematic characterization of proteome alterations in disease states.

Main Results:

Identification of critical areas for proteomics research: resource building, understanding biological variation, and disease-specific characterization.
Highlighting the need for a structured, milestone-driven approach.
Emphasizing the necessity of organized and collaborative scientific endeavors.

Conclusions:

A coordinated roadmap is essential for advancing the field of proteomics.
Focusing on resource development, biological variability, and disease states will enhance clinical relevance.
Collaborative efforts are key to achieving comprehensive proteome understanding and application.